Zenas BioPharma (ZBIO) Competitors $16.32 +0.70 (+4.48%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock ZBIO vs. FOLD, BCRX, CLDX, DVAX, INVA, MNKD, NVAX, OPK, GERN, and RGLSShould you be buying Zenas BioPharma stock or one of its competitors? The main competitors of Zenas BioPharma include Amicus Therapeutics (FOLD), BioCryst Pharmaceuticals (BCRX), Celldex Therapeutics (CLDX), Dynavax Technologies (DVAX), Innoviva (INVA), MannKind (MNKD), Novavax (NVAX), OPKO Health (OPK), Geron (GERN), and Regulus Therapeutics (RGLS). These companies are all part of the "biotechnology" industry. Zenas BioPharma vs. Its Competitors Amicus Therapeutics BioCryst Pharmaceuticals Celldex Therapeutics Dynavax Technologies Innoviva MannKind Novavax OPKO Health Geron Regulus Therapeutics Amicus Therapeutics (NASDAQ:FOLD) and Zenas BioPharma (NASDAQ:ZBIO) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, profitability, earnings, media sentiment, dividends, analyst recommendations and institutional ownership. Do analysts prefer FOLD or ZBIO? Amicus Therapeutics presently has a consensus price target of $16.22, indicating a potential upside of 158.32%. Zenas BioPharma has a consensus price target of $36.67, indicating a potential upside of 124.67%. Given Amicus Therapeutics' higher probable upside, research analysts plainly believe Amicus Therapeutics is more favorable than Zenas BioPharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Amicus Therapeutics 0 Sell rating(s) 2 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.80Zenas BioPharma 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher valuation & earnings, FOLD or ZBIO? Amicus Therapeutics has higher revenue and earnings than Zenas BioPharma. Amicus Therapeutics is trading at a lower price-to-earnings ratio than Zenas BioPharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmicus Therapeutics$528.29M3.66-$56.11M-$0.09-69.78Zenas BioPharma$5M136.53-$156.99M-$3.55-4.60 Does the media prefer FOLD or ZBIO? In the previous week, Amicus Therapeutics had 6 more articles in the media than Zenas BioPharma. MarketBeat recorded 7 mentions for Amicus Therapeutics and 1 mentions for Zenas BioPharma. Amicus Therapeutics' average media sentiment score of 0.92 beat Zenas BioPharma's score of 0.00 indicating that Amicus Therapeutics is being referred to more favorably in the media. Company Overall Sentiment Amicus Therapeutics Positive Zenas BioPharma Neutral Is FOLD or ZBIO more profitable? Zenas BioPharma has a net margin of 0.00% compared to Amicus Therapeutics' net margin of -5.41%. Amicus Therapeutics' return on equity of 4.67% beat Zenas BioPharma's return on equity.Company Net Margins Return on Equity Return on Assets Amicus Therapeutics-5.41% 4.67% 1.05% Zenas BioPharma N/A N/A N/A SummaryAmicus Therapeutics beats Zenas BioPharma on 9 of the 12 factors compared between the two stocks. Get Zenas BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for ZBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ZBIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZBIO vs. The Competition Export to ExcelMetricZenas BioPharmaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$653.45M$3.06B$5.70B$9.48BDividend YieldN/A2.37%4.59%3.99%P/E RatioN/A8.3320.9817.21Price / Sales136.53321.08443.32103.11Price / CashN/A43.2336.5558.97Price / Book2.188.308.635.90Net Income-$156.99M-$55.19M$3.24B$258.42M7 Day Performance23.82%5.07%3.22%1.94%1 Month Performance62.87%17.61%10.72%12.02%1 Year PerformanceN/A7.03%34.94%20.80% Zenas BioPharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZBIOZenas BioPharma1.1324 of 5 stars$16.32+4.5%$36.67+124.7%N/A$653.45M$5M0.00N/AFOLDAmicus Therapeutics4.0443 of 5 stars$6.22+2.8%$16.22+160.8%-38.8%$1.92B$528.29M-69.10480News CoverageUpcoming EarningsBCRXBioCryst Pharmaceuticals4.5154 of 5 stars$8.65+1.5%$16.70+93.1%+15.3%$1.81B$450.71M-33.27530CLDXCelldex Therapeutics1.7577 of 5 stars$22.36+1.4%$50.11+124.1%-38.5%$1.48B$7.02M-8.28150DVAXDynavax Technologies4.3973 of 5 stars$11.18+2.2%$24.00+114.7%+3.7%$1.34B$277.25M-21.50350Positive NewsINVAInnoviva4.0666 of 5 stars$19.28-1.1%$40.33+109.2%+8.2%$1.21B$358.71M-19.09100Upcoming EarningsMNKDMannKind2.9707 of 5 stars$3.93+2.9%$10.14+158.1%-30.4%$1.19B$297.60M39.30400Analyst ForecastAnalyst RevisionNVAXNovavax4.2947 of 5 stars$7.22+0.7%$15.86+119.6%-52.2%$1.17B$682.16M2.721,990News CoverageAnalyst ForecastOptions VolumeGap UpOPKOPKO Health3.6179 of 5 stars$1.38-1.4%$2.75+99.3%-0.3%$1.09B$713.10M-19.712,997GERNGeron3.4065 of 5 stars$1.28+4.1%$4.61+260.2%-71.2%$815.26M$76.99M-6.0970Analyst RevisionRGLSRegulus Therapeutics1.7317 of 5 stars$8.16flat$8.50+4.2%N/A$564.92MN/A-11.1830 Related Companies and Tools Related Companies FOLD Alternatives BCRX Alternatives CLDX Alternatives DVAX Alternatives INVA Alternatives MNKD Alternatives NVAX Alternatives OPK Alternatives GERN Alternatives RGLS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ZBIO) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersElon Just Fired the IRS Agents Targeting Your SavingsElon Musk just fired 6,700 IRS agents — and exposed a war on your retirement. While D.C. scrambles to regai...Priority Gold | SponsoredWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredTrump’s Endgame? (R.I.P. China)Tucked inside a Silicon Valley factory, a bold new tech is quietly emerging—one that could ignite a $12 trilli...Brownstone Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zenas BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zenas BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ZBIO Stock Alerts